David M. Miller

机构：Harvard University, Massachusetts General Hospital, Global Cancer Institute · ORCID：0000-0001-9736-9119

发表论文 166 篇 · 总被引 6216 次 · h-index 37

代表论文

• Neoadjuvant cemiplimab and surgery for stage II–IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study (2023 · The Lancet Oncology · 被引 106)
• Neoadjuvant-Intent Immunotherapy in Advanced, Resectable Cutaneous Squamous Cell Carcinoma (2024 · JAMA Otolaryngology–Head & Neck Surgery · 被引 29)
• The prognostic value of the Merkel cell polyomavirus serum antibody test: A dual institutional observational study (2024 · Cancer · 被引 7)
• Immunotherapy for Advanced Conjunctival Squamous Cell Carcinoma: Treatment Failures (2025 · Ophthalmic Plastic and Reconstructive Surgery · 被引 5)
• A dual institution real-world study of avelumab for advanced Merkel cell carcinoma. (2023 · Journal of Clinical Oncology · 被引 4)
• The evolving treatment landscape for CSCC (2025 · Archives of Dermatological Research · 被引 2)